azelaic acid and glutathione together Good Molecules - 10% Treatment Brighten. Protect. Glow. @cattandco.ph 𝗨𝗻𝗱𝗲𝗿𝗮𝗿𝗺

Healthy aging support from within

Conclusions and Recommendations Key messages for at-risk populations: The EVOKE trial failure does not invalidate GLP-1 agonists for preventionthe epidemiological signal remains strong, and these drugs may provide metabolic and cardiovascular benefits with potential cognitive co-benefits when used for approved indications SS-31s approval establishes precedent for mitochondrial-targeted therapeuticswatch this space for expanded indications Popular biohacker peptides (BPC-157, Dihexa, P21) have essentially no human cognitive evidence

Solvent Mismatch Some peptides do not dissolve well in neutral water alone

However, not all vitamin C creates this problem

Category 3, with the most rigorous facilities and testing, can assign BUDs up to 180 days